Skip Navigation

Research Funding

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

June 2014 DAIT Council-Approved Concepts

Concepts represent early planning stages for program announcements, requests for applications, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to the Opportunities and Announcements portal.

NB: Council approval does not guarantee that a concept will become an initiative.

Table of Contents

Radiological and Nuclear Medical Countermeasure Product Development Program

For the published program announcement, see the December 10, 2014, Guide announcement, Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR) (R43/R44).

Immune Defense Mechanisms at the Mucosa Cooperative Studies Group

For the published request for applications, see the May 26, 2015, Guide announcement, Mucosal Immunology Studies Team (MIST) (U01).

Asthma and Allergic Diseases Cooperative Research Centers

Request for Applications

Contact: Gang Dong

Objective: With the continuing increase in the prevalence of asthma and allergic diseases worldwide, this program aims to promote innovative, multidisciplinary, and translational research on asthma and allergic diseases. The overarching goal of the program is to improve the diagnosis and treatment of asthma and allergic diseases and provide a strong scientific foundation for developing effective prevention strategies.

Description: The initiative will support NIAID's unique and long-standing Asthma and Allergic Diseases Cooperative Research Centers (AADCRC) program, which funds research centers across the U.S. to conduct interdisciplinary and translational research in asthma and allergic diseases. The Centers coordinate their efforts through a steering committee and collaborate with each other through an opportunity fund that supports small, independent pilot studies. This is a renewal initiative and no substantial change in the overall goal is anticipated. A change in duration of awards from five years to seven years will be proposed. Longer grant duration allows the program to accommodate clinical trials of immune modulation and longitudinal cohort studies that are required towards the goal of asthma and allergic diseases prevention.

Last Updated May 27, 2015

Last Reviewed May 27, 2015